IRX-2, a novel immunotherapeutic, enhances and protects NK-cell functions in cancer patients

B. Schilling, E. S. Halstead, P. Schuler, M. Harasymczuk, J. E. Egan, T. L. Whiteside

Research output: Contribution to journalArticlepeer-review

12 Scopus citations

Fingerprint Dive into the research topics of 'IRX-2, a novel immunotherapeutic, enhances and protects NK-cell functions in cancer patients'. Together they form a unique fingerprint.

Medicine & Life Sciences